Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GVCDI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD22 antibody-drug conjugate (Ambrx)
|
|||||
| Synonyms |
Anti-CD22 antibody-drug conjugate (Ambrx)
Click to Show/Hide
|
|||||
| Organization |
Ambrx, Inc.; Ambrx Biopharma, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
B-cell lymphoma [ICD11:2A86]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.